Related references
Note: Only part of the references are listed.Combination of Olanzapine and Samidorphan Has No Clinically Significant Effect on the Pharmacokinetics of Lithium or Valproate
Lei Sun et al.
CLINICAL DRUG INVESTIGATION (2020)
Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study
Christoph U. Correll et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study
Lei Sun et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)
Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study
Steven G. Potkin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2020)
A Phase I Open-Label Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Olanzapine and Samidorphan Administered in Combination in Healthy Human Subjects
Lei Sun et al.
CLINICAL DRUG INVESTIGATION (2019)
Effect of Food on the Pharmacokinetics of a Combination of Olanzapine and Samidorphan
Lei Sun et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
Effect of hepatic and renal impairment on the pharmacokinetics of olanzapine and samidorphan given in combination as a bilayer tablet
Lei Sun et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled Study
Sanjeev Pathak et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia
William F. Martin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Bioequivalence of Olanzapine Given in Combination With Samidorphan as a Bilayer Tablet (ALKS 3831) Compared With Olanzapine-Alone Tablets: Results From a Randomized, Crossover Relative Bioavailability Study
Lei Sun et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
Clinical Pharmacokinetics of Atypical Antipsychotics: An Update
Massimo Carlo Mauri et al.
CLINICAL PHARMACOKINETICS (2018)
A History of the Pharmacological Treatment of Bipolar Disorder
Francisco Lopez-Munoz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder
Jean M. Bidlack et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers
Bernard L. Silverman et al.
SCHIZOPHRENIA RESEARCH (2018)
Pharmacokinetics and Short-term Safety of ALKS 3831, a Fixed-dose Combination of Olanzapine and Samidorphan, in Adult Subjects with Schizophrenia
Lei Sun et al.
CLINICAL THERAPEUTICS (2018)
Population pharmacokinetics analysis of olanzapine for Chinese psychotic patients based on clinical therapeutic drug monitoring data with assistance of meta-analysis
Anyue Yin et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Single- and Multiple-dose Pharmacokinetics of Samidorphan, A Novel Opioid Antagonist, in Healthy Volunteers
Ryan Turncliff et al.
CLINICAL THERAPEUTICS (2015)
Use of Remifentanil in a Novel Clinical Paradigm to Characterize Onset and Duration of Opioid Blockade by Samidorphan, a Potent μ-Receptor Antagonist
Megan J. Shram et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania
A. Yildiz et al.
PSYCHOLOGICAL MEDICINE (2015)
In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine Metabolism
Porntipa Korprasertthaworn et al.
DRUG METABOLISM AND DISPOSITION (2015)
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht et al.
LANCET (2013)
Mice lacking δ-opioid receptors resist the development of diet-induced obesity
Traci A. Czyzyk et al.
FASEB JOURNAL (2012)
The Impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on Prescribing Practices: An Analysis of Data From a Large Midwestern State
Rachel L. Berkowitz et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis
Andrea Cipriani et al.
LANCET (2011)
κ-Opioid receptors control the metabolic response to a high-energy diet in mice
Traci A. Czyzyk et al.
FASEB JOURNAL (2010)
Modeling the Effectiveness of Paliperidone ER and Olanzapine in Schizophrenia: Meta-Analysis of 3 Randomized, Controlled Clinical Trials
Ignacio Ortega et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Oral Olanzapine Disposition in Adolescents with Schizophrenia or Bipolar I Disorder
Evelyn D. Lobo et al.
PEDIATRIC DRUGS (2010)
Syntheses of novel high affinity ligands for opioid receptors
Mark P. Wentland et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
Brian J. Anderson et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Olanzapine Plasma Concentrations After Treatment With 10, 20, and 40 mg/d in Patients With Schizophrenia An Analysis of Correlations With Efficacy, Weight Gain, and Prolactin Concentration
Leslie Citrome et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Sex, race, and smoking impact olanzapine exposure
Kristin L. Bigos et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Likelihood based approaches to handling data below the quantification limit using NONMEM VI
Jae Eun Ahn et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2008)
Association of the mu-opioid receptor gene with type 2 diabetes mellitus in an African American population
CJ Gallagher et al.
MOLECULAR GENETICS AND METABOLISM (2006)
Resistance to diet-induced obesity in μ-opioid receptor-deficient mice:: Evidence for a thrifty gene
A Tabarin et al.
DIABETES (2005)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
